Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort

MLA

Julián Torre-Cisneros, et al. “Ceftazidime-Avibactam in the Treatment of Infections Caused by KPC-Producing Klebsiella Pneumoniae: Factors Associated with Clinical Efficacy in a Single-Center Cohort.” International Journal of Antimicrobial Agents, vol. 56, Sept. 2020, p. 106075. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2020.106075.

APA

Julián Torre-Cisneros, M Recio, Monserrat Muñoz, Manuel García, Marina Gallo, Angela Cano, Isabel Machuca, Luis Martínez-Martínez, Juan José Castón, Antonio Escribano, Irene Gracia-Aufinger, Elena Pérez-Nadales, & Julia Guzmán-Puche. (2020). Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort. International Journal of Antimicrobial Agents, 56, 106075. https://doi.org/10.1016/j.ijantimicag.2020.106075

Chicago

Julián Torre-Cisneros, M Recio, Monserrat Muñoz, Manuel García, Marina Gallo, Angela Cano, Isabel Machuca, et al. 2020. “Ceftazidime-Avibactam in the Treatment of Infections Caused by KPC-Producing Klebsiella Pneumoniae: Factors Associated with Clinical Efficacy in a Single-Center Cohort.” International Journal of Antimicrobial Agents 56 (September): 106075. doi:10.1016/j.ijantimicag.2020.106075.